Friday, October 23, 12 to 1 p.m. ET
Dr. Carlson will describe the vision and mission of CAN-PACT along with their six major objectives, which include capacity building, patient-driven research priority setting, educating research trainees, psychedelic assisted therapy providers, clinicians, patients and the public, conducting clinical trials on psilocybin-assisted therapy, and engaging with Canadian policymakers at all levels. She will update progress on these objectives and focus on the PAT-MIND clinical trial about to be launched.
Featuring:
Dr. Linda Carlson holds the Enbridge Research Chair in Psychosocial Oncology and is a Full Professor in the Department of Oncology, Cumming School of Medicine at the University of Calgary. She directs the Alberta Complementary Therapy and Integrative Oncology (ACTION) Centre and has provided clinical care at Cancer Care Alberta since 1997. A globally recognized leader in mindfulness-based cancer recovery and integrative oncology, Dr. Carlson has published over 260 peer-reviewed papers, dozens of book chapters, co-authored influential books, and received numerous prestigious awards, including the 2023 Dr. Rogers Prize for Excellence in Complementary and Alternative Medicine. She also serves as Co-Editor-in-Chief of the Journal of Psychosocial Oncology Research and Practice, is Past-President of the Society for Integrative Oncology and Director of Finance for the International Society for Contemplative Research. Since 2025 she also leads the Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT).
The views and information presented in this webinar are those of the individual speakers and do not necessarily reflect the views of the Society for Integrative Oncology (SIO). SIO does not endorse or assume responsibility for any products, treatments, claims, or recommendations discussed. This webinar is provided for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.